Nairovylex R

Q: What is Nairovylex R email address?

Email Nairovylex R at nairovylex.r@mssm.edu. This email is the most updated Nairovylex R's email found in 2026.

Q: How to contact Nairovylex R?

To contact Nairovylex R send an email to nairovylex.r@mssm.edu. (updated on September 05, 2024)

Clinical Research Coordinator II at Icahn School of Medicine at Mount Sinai | United States

About Nairovylex R

Nairovylex R. is an accomplished Clinical Research Coordinator II at the Icahn School of Medicine at Mount Sinai, where she plays a pivotal role in advancing clinical research in the fields of psychology and neuropsychology. With a Master’s degree in Psychology from Medaille University, she brings a wealth of knowledge and expertise to her current position, particularly in the areas of traumatic brain injury, neurodegenerative disorders, and cognitive rehabilitation. Her passion for understanding the intricacies of cognitive health within diverse populations drives her commitment to impactful research.

Currently, Nairovylex is actively engaged in a funded research project under the National Human Genome Research Institute (NHGRI) as part of the eMERGE Network. In this capacity, she is responsible for researching and recruiting participants from both internal medicine and pediatric departments. Her work focuses on elucidating genomic risk assessments related to polygenic risk factors for various conditions, including heart disease, diabetes mellitus, hypercholesterolemia, asthma, and cancer. By leveraging her strong skills in literature review, data analysis using SPSS, and participant management through RedCap software, Nairovylex ensures that the research is conducted with the utmost rigor and integrity.

Her proficiency in clinical trials, coupled with her ability to communicate effectively in both English and Spanish, enhances her capability to engage with diverse participant populations. Nairovylex's leadership and teamwork skills further contribute to her success in coordinating complex research initiatives, making her a valuable asset to the Icahn School of Medicine and the broader research community. Through her work, she aims to bridge the gap between genomic research and clinical applications, ultimately contributing to improved health outcomes for individuals at risk of various diseases.

Nairovylex R Work